Experiencing chest pain that doesn’t go away, shortness of breath, or the unsettling thump of a racing heartbeat can be frightening. For many, these signs may indicate pericarditis, a condition ...

The American College of Cardiology (ACC) reported January 4, 2023, that new research on treatment of recurrent pericarditis involving cardiac magnetic resonance imaging and interlukin-1 inhibitors may ...

Did you know that bacteria and viruses can even attack your heart? Periarditis is one of the result of heart infection. Did you know that your heart can also get infected or inflamed? Yes, there are ...

HAMILTON, Bermuda, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company focused on discovering, acquiring, developing and ...

This is a Designated News Release. Toronto, Ontario--(Newsfile Corp. - February 15, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life ...

HAMILTON, Bermuda, July 16, 2020 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company focused on discovering, acquiring, developing and ...

Global pericarditis treatment market is likely to be worth US$ 3.60 Billion in 2022, and is anticipated to grow at a CAGR of 5.24% during the projected period, reaching US$ 6 Billion by 2032.

LONDON--(BUSINESS WIRE)--The global pericarditis drugs market is expected to post a CAGR of more than 4% during the period 2019-2023, according to the latest market research report by Technavio. A key ...

HAMILTON, Bermuda, July 16, 2020 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company focused on discovering, acquiring, developing and ...